Fig. 4: OS of male versus female patients by genomic alterations.
From: Sex disparity in survival outcomes of advanced gastric adenocarcinoma
A OS by KRAS mutation. B OS by CDKN2A mutation. C OS by PI3KCA mutation.
Fig. 4: OS of male versus female patients by genomic alterations. | BJC Reports
